Literature DB >> 9442394

Essential functions of Pax-5 (BSAP) in pro-B cell development.

S L Nutt1, C Thévenin, M Busslinger.   

Abstract

Pax-5 codes for the transcription factor BSAP which is expressed in all B-lymphoid tissues in addition to the developing central nervous system and testis. Within the B-lymphoid lineage, Pax-5 expression is already detected in the earliest B cell progenitors and persists up to the mature B cell stage. Targeted inactivation of the Pax-5 gene in the mouse germline revealed a differential dependency of fetal and adult B-lymphopoiesis on this transcription factor. Pax-5 is required for the differentiation of the earliest B-lineage-committed precursor cells in the fetal liver. In contrast, B cell development in the adult bone marrow progresses up to an early pro-B cell stage in the absence of Pax-5 function. The expression of CD19, Ig alpha (mb-1) and N-myc is severely reduced in Pax-5-deficient pro-B cells. These BSAP target genes are, however, unlikely to explain the early developmental block based on their known function in B cell development. Moreover, VH-to-DHJH rearrangements at the immunoglobulin heavy-chain locus are approximately 50-fold reduced in Pax-5-deficient pro B-cells, while the DH-to-JH rearrangements occur at a normal frequency. However, the expression of rearranged mu heavy-chain transgenes does not allow Pax-5-deficient pro-B cells to develop further to the pre-B cell stage. Together these data demonstrate therefore that B cell development in the Pax-5 deficient bone marrow is arrested at an early pro-B cell stage which is not yet responsive to pre-B cell receptor signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9442394     DOI: 10.1016/S0171-2985(97)80043-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes.

Authors:  Michèle Milili; Laurent Gauthier; Julie Veran; Marie-Geneviève Mattei; Claudine Schiff
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

Review 4.  A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem Cells to Mature B Lymphocytes.

Authors:  Vivian Y Lim; Sandra Zehentmeier; Chris Fistonich; João P Pereira
Journal:  Adv Immunol       Date:  2017-03-18       Impact factor: 3.543

5.  B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.

Authors:  Suchita Hodawadekar; Duonan Yu; Diana Cozma; Bruce Freedman; Oriol Sunyer; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  Exp Cell Res       Date:  2006-10-25       Impact factor: 3.905

6.  A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription.

Authors:  Nickolai A Barlev; Alexander V Emelyanov; Paola Castagnino; Philip Zegerman; Andrew J Bannister; Manuel A Sepulveda; Flavie Robert; Laszlo Tora; Tony Kouzarides; Barbara K Birshtein; Shelley L Berger
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome.

Authors:  M Babjuk; V Soukup; J Mares; J Dusková; Z Sedlácek; M Trková; L Pecen; J Dvorácek; T Hanus; R Kocvara; J Novák; C Povýsil
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

8.  PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation.

Authors:  Charlotte Cresson; Sophie Péron; Laura Jamrog; Nelly Rouquié; Nais Prade; Marine Dubois; Sylvie Hébrard; Stéphanie Lagarde; Bastien Gerby; Stéphane J C Mancini; Michel Cogné; Eric Delabesse; Laurent Delpy; Cyril Broccardo
Journal:  Oncotarget       Date:  2018-08-28

Review 9.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

Review 10.  Molecular Regulation of Differentiation in Early B-Lymphocyte Development.

Authors:  Mikael Sigvardsson
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.